TABLE 2.
Subjects | Sex | Model | Effect | Reference |
---|---|---|---|---|
β-Endorphin KO | Male + female | [1] 2-Bottle choice (24 h, 7%); | [1] Increase (intake and preference); | Grisel et al. (1999) |
[2] 2-Bottle choice (24 h, 10%) | [2] No difference (intake or preference) | |||
β-Endorphin KO | Male | [1] 2-Bottle choice (24 h, 10%); | [1] No difference (intake); | Grahame et al. (2000) |
[2] 2-Bottle choice (2 h, 10%); | [2] Increase (intake); | |||
[3] ADE | [3] Increase (intake) | |||
β-Endorphin KO | Male, female | 2-Bottle choice (24 h, 16%); | Decrease (intake and preference) with sex difference | Racz et al. (2008) |
Tpit KO mice with pituitary-specific POMC deletion | Male, female | 1-Bottle (4 h, 15%) in DID | No difference in intake or preference in either sex | Zhou et al. (2017c) |
nPE KO mice with hypothalamic-specific POMC deletion | Male, female | [1] 1-Bottle (4 h, 7.5%–30%) in DID; | Decrease (intake and preference) in all three models, with sex difference | Zhou et al. (2017c) |
[2] 2-Bottle choice (24 h, every other day, 7.5%–30%) in IA; | ||||
[3] ADE | ||||
MOP-r KO | Male | [1] 30-min Operant self-administration (10%); | [1] Decrease (intake); | Roberts et al. (2000) |
[2] 2-Bottle choice (24 h, 10%) | [2] Decrease (intake and preference) | |||
MOP-r KO | Male, female | [1] 2-Bottle choice (24 h, 2%–32%); | [1] Decrease (intake) with sex difference; | Hall et al. (2001) |
[2] CPP | [2] Decrease | |||
MOP-r KO with striatum-specific deletion | Male | [1] 2-Bottle choice (24 h, 10%); | [1] Decrease (intake and preference); | Ben Hamida et al. (2018) |
[2] 2-Bottle choice (24 h, every other day, 10%) in IA; | [2] Decrease (intakeand preference); | |||
[3] CPP | [3] Decrease |
KO, knockout; nPE, neuronal Pomc enhancers.